May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
A comparison of plasma and vitreous levels of angiogenic factors [Vascular Endothelial Growth Factor, soluble VEGF receptor, Angiopoietin 1 & 2, and angiopoietin receptor TIE 2] in proliferative diabetic retinopathy
Author Affiliations & Notes
  • Y.K. Ghosh
    Ophthalmology, Birmingham and Midland Eye Centre, Birmingham, United Kingdom
  • A.V. Reginald
    Ophthalmology, Birmingham and Midland Eye Centre, Birmingham, United Kingdom
  • S. Banerjee
    Ophthalmology, Birmingham and Midland Eye Centre, Birmingham, United Kingdom
  • S. Dhingra
    Ophthalmology, Birmingham and Midland Eye Centre, Birmingham, United Kingdom
  • A.K. Tyagi
    Ophthalmology, Birmingham and Midland Eye Centre, Birmingham, United Kingdom
  • G.Y. H. Lip
    Cardiovascular Medicine, City Hospital, Birmingham, United Kingdom
  • Footnotes
    Commercial Relationships  Y.K. Ghosh, None; A.V. Reginald, None; S. Banerjee, None; S. Dhingra, None; A.K. Tyagi, None; G.Y.H. Lip, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 2498. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y.K. Ghosh, A.V. Reginald, S. Banerjee, S. Dhingra, A.K. Tyagi, G.Y. H. Lip; A comparison of plasma and vitreous levels of angiogenic factors [Vascular Endothelial Growth Factor, soluble VEGF receptor, Angiopoietin 1 & 2, and angiopoietin receptor TIE 2] in proliferative diabetic retinopathy . Invest. Ophthalmol. Vis. Sci. 2004;45(13):2498.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To compare plasma and vitreous levels of angiogenic factors [Vascular Endothelial Growth Factor (VEGF, in index of angiogenesis), soluble VEGF receptor (sFlt–1), Angiopoietin 1 & 2 (Ang–1, Ang–2) and soluble angiopoietin receptor TIE 2 (tie–2)] in patients with proliferative diabetic retinopathy undergoing vitrectomy. Methods: 23 patients (18 male), mean age 51 years (range 25 to 72) with proliferative retinopathy secondary to diabetes and with no previous vitreo–retinal surgery were studied. Plasma and undiluted vitreous samples were obtained on the day of surgery. Plasma and vitreous levels of VEGF, sFLT–1, Ang 1 and 2 and tie 2 were assayed using ELISA. 

Results are median (inter–quartile range). P value for difference between plasma and vitreous levels, using 1–sample Wilcoxon test. Conclusions: Patients with proliferative diabetic retinopathy did not demonstrate statistically significant differenced between peripheral and vitreal markers of angiogenesis. As previous studies have shown significantly raised levels of angiogenic markers in proliferative diabetic retinopathy, plasma levels of these indices might be useful in determining patients at risk of developing proliferative retinopathy and provide an indicator for early treatment. A change in the plasma levels after vitrectomy may provide an opportunity for monitoring disease progression or relapse via a blood sample.

Keywords: diabetic retinopathy • retinal neovascularization • vitreoretinal surgery 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×